Boehringer Ingelheim Corporation's Ben Venue Laboratories to Shut Down Operations Permanently; 1,100 Staffers Handed Pink Slips

Ben Venue is axing jobs but others are hiring! Check it out! (Isn't it tempting?)

Cancer drug-maker Ben Venue Laboratories Inc. will stop production at its facilities by the end of the year, according to a press release issued by company officials today. The move means 1,100 employees at Bedford's largest employer -- which accounts for about 22 percent of the city's revenues -- will lose their jobs, through a phased reduction that will begin this month and continue into 2014. Employees are being notified in a series of employee meetings, said Boehringer Ingelheim Corp. U.S. spokeswoman Marjorie Moeling. Boehringer Ingelheim, based in Germany, has owned Ben Venue since 1997.

Don't forget, hundreds of biopharma companies are hiring! (We know you can't resist.)

Back to news